# EDGAR Filing Document

**Accession Number:** 0001540305
**File Stem:** 0000894189-23-001544
**Filing Date:** 2023-2
**Character Count:** 3570
**Document Hash:** a2181fdd946b605cfbeb1f7a6c43b8ab
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000894189-23-001544.hdr.sgml**: 20230227

**ACCESSION NUMBER**: 0000894189-23-001544

**CONFORMED SUBMISSION TYPE**: 497

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230227

**DATE AS OF CHANGE**: 20230227

**EFFECTIVENESS DATE**: 20230227

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ETF Series Solutions
- **CENTRAL INDEX KEY:** 0001540305
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1112

**FILING VALUES:**
- **FORM TYPE:** 497
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-179562
- **FILM NUMBER:** 23675227

**BUSINESS ADDRESS:**
- **STREET 1:** 615 EAST MICHIGAN ST
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202
- **BUSINESS PHONE:** 414-287-3700

**MAIL ADDRESS:**
- **STREET 1:** 615 EAST MICHIGAN ST
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202

## Series and Classes Contracts Data

### PSYK ETF (Series ID: S000072630)

---

|  |  |  |
|:---|:---|:---|
| Class Name | Ticker Symbol | Class ID   |
| PSYK ETF   | PSYK          | C000229024 |

---

## Series and Classes Contracts Data

### PSYK ETF (Series ID: S000072630)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000229024 | PSYK ETF     | PSYK            |

Filed Pursuant to Rule 497(e)

File Nos. 333-179562; 811-22668

**PSYK ETF (PSYK)**

**February 27, 2023**

**Supplement to the** 

**Summary Prospectus dated January 26, 2022, and** 

**the Prospectus and Statement of Additional Information ("SAI"),** 

**each dated January 25, 2022, as previously supplemented**

The Board of Trustees of ETF Series Solutions, upon a recommendation from Exchange Traded Concepts, LLC, the investment adviser to the PSYK ETF (the "Fund"), has determined to close and liquidate the Fund immediately after the close of business on March 28, 2023 (the "Liquidation Date"). Shares of the Fund are listed on the NYSE Arca, Inc.

Effective on or about March 21, 2023, the Fund will begin liquidating its portfolio assets. This will cause the Fund to increase its cash holdings and deviate from the investment objective and strategies stated in the Fund's prospectus.

The Fund will no longer accept orders for new creation units after the close of business on March 21, 2023, and trading in shares of the Fund will be halted prior to market open on the Liquidation Date. Prior to the Liquidation Date, shareholders may only be able to sell their shares to certain broker-dealers, and there is no assurance that there will be a market for the Fund's shares during that time period. Customary brokerage charges may apply to such transactions.

On or about the Liquidation Date, the Fund will liquidate its assets and distribute cash pro rata to all remaining shareholders. These distributions are taxable events. Distributions made to shareholders should generally be treated as received in exchange for shares and will therefore generally give rise to a capital gain or loss depending on a shareholder's tax basis. Shareholders should contact their tax advisor to discuss the income tax consequences of the liquidation. As calculated on the Liquidation Date, the Fund's net asset value will reflect the costs of closing the Fund, if any. Once the distributions are complete, the Fund will terminate. Proceeds of the liquidation will be sent to shareholders promptly after the Liquidation Date.

For additional information, please call 1-800-617-0004.

**Please retain this Supplement with your Summary Prospectuses, Prospectus, and SAI for future reference.**

<br>